Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1540159 · FYE Sep 30 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $5.25Day −2.05%Mkt cap $48M1Y +131.3%Off 52W high −74.2%Vol (1Y) 193.6%
Daily closing price, split-adjusted to the current basis; 3y shown of 2,524 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest3.2% of sh out |
| Days to cover5.4d |
| 13F net flow (QoQ)−5.27% |
| Top-10 13F concentration94.5% |
| Next report (est.)2026-08-12 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$0 |
| Earnings (TTM)-$10.4M |
| ROE−99.6% |
| ROIC−474.7% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+269.7% |
| 1Y+131.3% |
| 3Y−8.4% |
| 5Y−85.0% |
| 10Y−99.4% |
| Since incept. (ann.)−40.6% |
Total return through 2026-07-30 · series begins 2016-07-11. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)193.6% |
| Ann. volatility (3Y)142.6% |
| Sharpe (1Y)1.20 |
| Sharpe (3Y)0.56 |
| Max drawdown (1Y)−72.8% |
| Max drawdown (3Y)−88.4% |
| Beta (3Y vs SPY)2.45 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| Velan Capital Investment Management LP | 827,500 | $4M | 9.91% | +20.4% |
| Rubric Capital Management LP | 687,500 | $4M | 8.24% | +0.0% |
| PERCEPTIVE ADVISORS LLC | 563,239 | $3M | 6.75% | new |
| JANE STREET GROUP, LLC | 115,721 | $605,221 | 1.39% | new |
| VANGUARD CAPITAL MANAGEMENT LLC | 85,966 | $449,602 | 1.03% | new |
| GEODE CAPITAL MANAGEMENT, LLC | 77,054 | $403,016 | 0.92% | +65.6% |
| VANGUARD FIDUCIARY TRUST CO | 38,446 | $201,073 | 0.46% | new |
| STATE STREET CORP | 37,979 | $198,630 | 0.45% | +103.3% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2021-09-30 | 2021-12-28 | — | — | $0 | −100.0% |
| 2021-06-30 | 2021-08-13 | — | — | $0 | −100.0% |
| 2021-03-31 | 2021-05-14 | — | — | $0 | −100.0% |
| 2020-12-31 | 2021-02-16 | — | — | $0 | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-12 is ESTIMATED from filing cadence (median gap 90d) — not company-confirmed.
